Table 2 of Men, Mol Vis 2017; 23:695-706.


Table 2. Additional IRD gene variants in CACNA1F patients.

Patient ID Gene Transcript Zygosity cDNA position Protein change Polyphen-2 SIFT Provean MutationTaster dbSNP ExAC Frequency
1 SEMA4A NM_022367.3 heterozygous c.2138G>A p.(Arg713Gln) Possibly damaging Tolerated Neutral Polymorphism rs41265017 A=4,297/ G=121,356
PDE6A NM_000440.2 heterozygous c.251A>T p.(Lys84Met) Benign Damaging Deleterious Polymorphism NA T=11/ A=121,396
PDE6B NM_000283.3 heterozygous c.1412C>T p.(Ala471Val) Benign Damaging Neutral Polymorphism rs182071364 T=17/ C=119,914
RPGR a NM_001034853.1 hemizygous c.1163C>T p.(Ala388Val) Benign Tolerated Neutral Polymorphism rs199661899 T=16/ C=85,833
2 USH2A NM_206933.2 heterozygous c.9286G>A p.(Val3096Met) Probably damaging Damaging Neutral Polymorphism rs147267500 A=6/ G=121,394
PDE6A NM_000440.2 heterozygous c.1214A>G p.(Asn405Ser) Probably damaging Damaging Deleterious Disease causing rs145107955 G=20/ A=121,278